Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract

Immunology

Volumn 128, Issue 1 PART 2, 2009, Pages

  Nkwanyana, Nonhlanhla N ^a   Gumbi, Pamela P ^a   Roberts, Lindi ^a   Denny, Lynette ^b   Hanekom, Willem ^a,b,c   Soares, Andreia ^b,c   Allan, Bruce ^a   Williamson, Anna Lise ^a,b   Coetzee, David ^d   Olivier, Abraham J ^a   Burgers, Wendy A ^a   Passmore, Jo Ann ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cervix; Genital; HIV; Inflammation; T cell

Indexed keywords

CD14 ANTIGEN; CD19 ANTIBODY; CD24 ANTIGEN; CD27 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; EFAVIRENZ; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LANGERIN; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; STAVUDINE; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ARTICLE; B LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LANGERHANS CELL; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MONOCYTE; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; VIRUS LOAD;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CERVIX UTERI; CHRONIC DISEASE; CYTOKINES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; MUCOUS MEMBRANE; NEUTROPHILS; VIRAL LOAD;

EID: 68249133729     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03077.x     Document Type: Article

References (52)

1. UNAIDS (2007) AIDS epidemic update. URL http://data.unaids.org/pub/ FactSheet/2008/(epi07-fs-regionalsummary-subsafrica-en.pdf) [accessed on 08 April 2009]
2. Johansson EL, Rudin A, Wassen L, Holmgren J. Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 1999 96 : 272 277.
3. Musey L, Ding Y, Cao J, Lee J, Galloway C, Yuen A, Jerome KR, McElrath MJ. Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes. J Virol 2003 77 : 291 300.
4. Anton PA, Elliott J, Poles MA et al. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. AIDS 2000 14 : 1761 1765.
5. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, Dandekar S. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003 77 : 11708 11717.
6. Shacklett BL, Yang O, Hausner MA et al. Optimization of methods to assess human mucosal T-cell responses to HIV infection. J Immunol Methods 2003 279 : 17 31.
7. Critchfield JW, Lemongello D, Walker DH, Garcia JC, Asmuth DM, Pollard RB, Shacklett BL. Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. J Virol 2007 81 : 5460 5471.
8. Musey L, Hu Y, Eckert L, Christensen M, Karchmer T, McElrath MJ. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J Exp Med 1997 185 : 293 303.
9. Shacklett BL, Cu-Uvin S, Beadle TJ et al. Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface. AIDS 2000 14 : 1911 1915.
10. Kaul R, Plummer FA, Kimani J et al. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1- resistant prostitutes in Nairobi. J Immunol 2000 164 : 1602 1611.
11. Prakash M, Patterson S, Kapembwa MS. Evaluation of the cervical cytobrush sampling technique for the preparation of CD45+ mononuclear cells from the human cervix. J Immunol Methods 2001 258 : 37 46.
12. Quayle AJ, Kourtis AP, Cu-Uvin S et al. T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women. J Acquir Immune Defic Syndr 2007 44 : 292 298.
13. Nicol AF, Frenandes ATG, Grinsztejn B et al. Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of HPV-infected women: Influence of HIV-1 coinfection. Diagn Mol Pathol 2005 14 : 39 47.
14. Rebbapragada A, Wachihi C, Pettengell C et al. Negative mucosal synergy between HSV-2 and HIV in the female genital tract. AIDS 2007 21 : 589 598.
15. Pudney J, Quayle AJ, Anderson DJ. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 2005 73 : 1253 1263.
16. Olaitan A, Johnson MA, MacLean A, Poulter LW. The distribution of immunocompetent cells in the genital tract of HIV-positive women. AIDS 1996 10 : 759 764.
17. Belec L, Gherardi R, Payan C, Prazuck T, Malkin JE, Tevi-Benissan C, Pillot J. Proinflammatory cytokine expression in cervicovaginal secretions of normal and HIV-infected women. Cytokine 1995 7 : 568 574.
18. Crowley-Nowick PA, Ellenberg JH, Vermund SH, Douglas SD, Holland CA, Moscicki AB. Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis 2000 181 : 939 945.
19. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 1989 86 : 2336 2340.
20. Fahrbach KM, Barry SM, Ayehunie S, Lamore S, Klausner M, Hope TJ. Activated CD34-derived Langerhans cells mediate traninfection with Human Immunodeficiency Virus. J Virol 2007 81 : 6858 6868.
21. Gumbi PP, Nkwanyana NN, Bere A et al. Impact of mucosal inflammation on cervical HIV-1-specific CD8 T cell responses in the female genital tract during chronic HIV infection. J Virol 2008 82 : 8529 8536.
22. Passmore JS, Milner M, Denny L et al. Mucosal T cell responses to HPV type 16 in women with HPV-associated CIN. Immunology 2006 119 : 507 14.
23. Thea DM, Porat R, Nagimbi K, Baangi M, St Louis ME, Kaplan G, Dinarello CA, Keusch GT. Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1. Ann Intern Med 1996 124 : 757 762.
24. Zara F, Nappi RE, Brerra R, Migliavacca R, Maserati R, Spinillo A. Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding. Sex Transm Infect 2004 80 : 108 112.
25. Cohen CR, Plummer FA, Mugo N et al. Increased interleukin-10 in the the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS 1999 13 : 327 332.
26. Bebell LM, Passmore JS, Williamson C, Mlisana C, Iriogbe I, Loggerenberg F, Abdool Karim Q, Abdool Karim S. Impact of elevated inflammatory cytokines in the female genital tract on CD4 destruction during acute HIV-1 infection. J Infect Dis 2008 198 : 710 14.
27. Cu-Uvin S, Hogan JW, Warren D et al. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis 1999 29 : 1145 1150.
28. Moodley P, Connolly C, Sturm AW. Interrelationships among HIV-1 infection, bacterial vaginosis, trichomoniasis and the presence of yeasts. J Infect Dis 2002 185 : 69 73.
29. Sobel JD. Gynecologic infections in HIV-infected women. Clin Infect Dis 2000 31 : 1225 1233.
30. Mitchell CM, Balkus J, Agnew KJ, Cohn S, Luque A, Lawler R, Coombs RW, Hitti JE. Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines. AIDS Res Hum Retroviruses 2008 24 : 667 671.
31. Tough DF, Sun S, Sprent J. T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med 1997 185 : 2089 2094.
32. Montano MA, Nixon CP, Ndung'u T, Bussmann H, Novitsky VA, Dickman D, Essex M. Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function. J Infect Dis 2000 181 : 76 81.
33. Bunnell R, Ekwaru JP, Solberg P et al. Changes in sexual behaviour and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006 20 : 85 92.
34. Wilson TE. Sexual and reproductive behaviour of women with HIV infection. Clin Obstet Gynaecol 2001 44 : 289 299.
35. Boily MC, Bastos FI, Desai K, Masse B. Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infection. Sex Transm Dis 2004 31 : 100 113.
36. McClelland RS, Baeton JM, Richardson BA, Layreys L, Emery S, Mandaliya K, Ndinya-Achola JO, Overbaugh J. Comparison of genital HIV-1 shedding and sexual risk behaviour among Kenyan women based on eligibility for initiation of HAART according to WHO guidelines. J Acquir Immune Defic Syndr 2006 41 : 611 615.
37. Scheer S, Chu PL, Klausner JD, Katz MH, Schwarcz SK. Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet 2001 357 : 432 435.
38. Taylor S, Pereira AS. Antiretroviral drug concentrations in semen of HIV-1 infected men. Sex Transm Infect 2001 77 : 4 11.
39. Lalani T, Hicks C. Does antiretroviral therapy prevent HIV transmission to sexual partners? Curr HIV/AIDS Rep 2007 4 : 80 85.
40. Mayer KH, Anderson DJ. Heterosexual HIV transmission. Infect Agents Dis 1995 4 : 273 284.
41. Smith JA. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 1994 56 : 672 686.
42. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006 6 : 173 182.
43. Decrion AZ, Dichamp I, Varin A, Herbein G. HIV and inflammation. Curr HIV Res 2005 3 : 243 259.
44. Poppe WA, Drijkoningen M, Ide PS, Lauweryns JM, Van Assche FA. Lymphocytes and dendritic cells in the normal uterine cervix. An immunohistochemical study. Eur J Obstet Gynecol Reprod Biol 1998 81 : 277 282.
45. Iqbal SM, Ball TB, Kimani J, Kiama P, Thottingal P, Embree JE, Fowke KR, Plummer FA. Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers. J Infect Dis 2005 192 : 728 738.
46. Douek DC, Brenchley JM, Betts MR, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002 417 : 95 98.
47. Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004 200 : 749 759.
48. Autran B, Carcelain G, Li TS et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997 277 : 112 116.
49. Altfeld M, Rosenberg ES, Shankarappa R et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 2001 193 : 169 180.
50. Guadalupe M, Sankaran S, George MD et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J Virol 2006 80 : 8236 8247.
51. Cheroutre H, Madakamutil L. Mucosal effector memory T cells: the other side of the coin. Cell Mol Life Sci 2005 62 : 2853 2866.
52. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004 22 : 745 763.